Analyses
| Type | Rating | Analysis | |
|---|---|---|---|
| (0) | Novo Nordisk Aktie: Kaufchance nach dem Crash? 🤔 On August 5th, 2026 by Börsenparkett | View analysis | |
| (1) | Novo Nordisk vs. Eli Lilly Aktien-Duell 2026 // Wo liegt die größere Chance? On April 17th, 2026 by Maximilian Gamperling | View analysis | |
| (0) | Abnehm-Markt explodiert! Novo Nordisk vs.Eli Lilly | Hol dir RENDITE! On March 10th, 2026 by Investment.Traders | View analysis | |
| (3) | Dividend Post Monats-Report Dezember: Eli Lilly im Portrait On January 7th, 2026 by The Dividend Post | View analysis | |
| (0) | Novo Nordisk Aktie: Ich KAUFE | Das ändert Alles! On December 24th, 2025 by Börsenparkett | View analysis | |
| (1) | Novo Nordisk vs. Eli Lilly On October 18th, 2025 by Finanzen Anders | View analysis | |
| (1) | Eli Lilly Aktie Update | Trump drückt Medikamentenpreise! On May 13th, 2025 by Investment.Traders | View analysis | |
| (0) | Novo Nordisk vs Eli Lilly: Aktien im Vergleich 2025 On April 24th, 2025 by Sebastian Legrand | View analysis | |
| (0) | Das Aktien-Duell der Giganten! | Eli Lilly VS. Novo Nordisk Aktie - Welche ist die Beste? On April 11th, 2025 by Investment.Traders | View analysis | |
| (1) | Eli Lilly Aktie Prognose 2025: Revolutionärer Durchbruch oder spekulative Blase? On February 13th, 2025 by FinMent | View analysis | |
| (0) | Eli Lilly Aktie! | Besser als Novo Nordisk? | Pharma Aktien Analyse On January 15th, 2025 by Börsenparkett | View analysis | |
| (0) | Eli Lilly Aktie - JETZT noch kaufen?! (Aktienanalyse 2024) On October 27th, 2024 by Sebastian Legrand | View analysis | |
| (1) | Eli Lilly Aktie Prognose 2024: Revolutionärer Durchbruch oder spekulative Blase? On February 7th, 2024 by FinMent | View analysis | |
| (2) | Eli Lilly Aktie Prognose 2024: Revolutionärer Durchbruch oder spekulative Blase? On December 18th, 2023 by FinMent | View analysis | |
| (3) | Eli Lilly vs. Novo Nordisk // Aktien-Duell 2023 // Übertreibung oder noch ein attraktiver Einstieg? On August 18th, 2023 by Maximilian Gamperling | View analysis |
Curated by Aktienfinder